(S) -Oxiracetam
(S) -oxiracetam (S-ORC) is an inhibitor targeting apoptosis. S-ORC reduces brain infarct size and lessens neurological dysfunction in middle cerebral artery occlusion/reperfusion (MCAO/R) models. S-ORC prevents neuronal apoptosis via activating PI3K/Akt/GSK3β signaling pathway via α7 nAChR after ischemic stroke. S-ORC can prevent neuronal death after ischemic stroke[1].
Product Specifications
CAS Number
[88929-35-5]
Product Name Alternative
(S) - (-) -Oxiracetam; (S) -ISF2522
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/s-oxiracetam.html
Purity
99.56
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(CN1C(C[C@@H](C1)O)=O)N
Molecular Formula
C6H10N2O3
Molecular Weight
158.16
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MMP19, CT (Matrix Metalloproteinase-19, MMP-19, Matrix Metalloproteinase RASI, Matrix Metalloproteinase-18, MMP-18, MMP18, RASI) (MaxLight 750) discontinued
